IL159215A0 - A solution of interleukin-13 and methods utilizing the same - Google Patents

A solution of interleukin-13 and methods utilizing the same

Info

Publication number
IL159215A0
IL159215A0 IL15921502A IL15921502A IL159215A0 IL 159215 A0 IL159215 A0 IL 159215A0 IL 15921502 A IL15921502 A IL 15921502A IL 15921502 A IL15921502 A IL 15921502A IL 159215 A0 IL159215 A0 IL 159215A0
Authority
IL
Israel
Prior art keywords
interleukin
solution
same
methods utilizing
utilizing
Prior art date
Application number
IL15921502A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL159215A0 publication Critical patent/IL159215A0/xx

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL15921502A 2001-06-07 2002-05-16 A solution of interleukin-13 and methods utilizing the same IL159215A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29660701P 2001-06-07 2001-06-07
PCT/US2002/015561 WO2002101629A1 (en) 2001-06-07 2002-05-16 Solution structure of il-13 and uses thereof

Publications (1)

Publication Number Publication Date
IL159215A0 true IL159215A0 (en) 2004-06-01

Family

ID=23142750

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15921502A IL159215A0 (en) 2001-06-07 2002-05-16 A solution of interleukin-13 and methods utilizing the same

Country Status (9)

Country Link
US (1) US20030013851A1 (es)
EP (1) EP1402451A4 (es)
JP (1) JP2005506960A (es)
AR (1) AR036333A1 (es)
CA (1) CA2450147A1 (es)
IL (1) IL159215A0 (es)
MX (1) MXPA03011158A (es)
WO (1) WO2002101629A1 (es)
ZA (1) ZA200309894B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501121B2 (en) * 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
AR049390A1 (es) * 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7774811B2 (en) * 2004-08-26 2010-08-10 Sony Corporation Method and system for use in displaying multimedia content and status
CA2587903A1 (en) * 2004-11-17 2006-05-26 Amgen Fremont Inc. Fully human monoclonal antibodies to il-13
ES2902063T3 (es) 2006-09-08 2022-03-24 Abbvie Bahamas Ltd Proteínas de unión a interleucina-13
TW200848429A (en) * 2007-04-23 2008-12-16 Wyeth Corp Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
WO2010021874A2 (en) 2008-08-20 2010-02-25 Centocor Ortho Biotech Inc. Engineered anti-il-13 antibodies, compositions, methods and uses
US9512194B2 (en) 2012-01-27 2016-12-06 The Board Of Trustees Of The Leland Stanford Junior University Modified IL-13 polypeptides
JP6936934B2 (ja) 2013-09-24 2021-09-22 メディシナ セラピューティクス インコーポレイテッド インターロイキン−４受容体結合融合タンパク質及びその使用
CN108277226A (zh) * 2018-02-01 2018-07-13 北京市华信行生物科技有限公司 白细胞介素-6的编码基因及其制备方法和应用
MX2020014027A (es) 2018-06-25 2021-03-09 Univ Washington Dise?o de novo de mimeticos de interleucina potentes y selectivos.
WO2020106708A1 (en) * 2018-11-20 2020-05-28 University Of Washington Split interleukin mimetics and their use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5331573A (en) * 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
CA2142860A1 (en) * 1992-08-21 1994-03-03 Gregorio Aversa Human interleukin-13
US5856116A (en) * 1994-06-17 1999-01-05 Vertex Pharmaceuticals, Incorporated Crystal structure and mutants of interleukin-1 beta converting enzyme
US5614191A (en) * 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
US5710023A (en) * 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
JP2000319298A (ja) * 1999-03-04 2000-11-21 Seibutsu Bunshi Kogaku Kenkyusho:Kk 蛋白質複合体の結晶、構造座標、及び構造座標の使用
JP2001069995A (ja) * 1999-07-02 2001-03-21 Japan Tobacco Inc 結晶構造解析に適したｈｃｖポリメラーゼ及びその利用方法
US6795776B1 (en) * 1999-10-14 2004-09-21 Bristol-Myers Squibb Company Crystallographic structure of the androgen receptor ligand binding domain
EP1232253A2 (en) * 1999-11-16 2002-08-21 Vertex Pharmaceuticals Incorporated Crystallizable compositions comprising a caspase-7
US20040137518A1 (en) * 2002-01-31 2004-07-15 Lambert Millard Hurst CRYSTALLIZED PPARa LIGAND BINDING DOMAIN POLYPEPTIDE AND SCREENING METHODS EMPLOYING SAME

Also Published As

Publication number Publication date
JP2005506960A (ja) 2005-03-10
WO2002101629A1 (en) 2002-12-19
MXPA03011158A (es) 2004-02-27
AR036333A1 (es) 2004-09-01
EP1402451A1 (en) 2004-03-31
ZA200309894B (en) 2004-09-29
CA2450147A1 (en) 2002-12-19
EP1402451A4 (en) 2005-01-05
US20030013851A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
EP1463742A4 (en) NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
AU2002364528A8 (en) Bio-implant and method of making the same
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
HUP0401534A3 (en) Modified factor ix
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
PL373702A1 (en) Honeycomb structural body and assembly thereof
AU2002352903A8 (en) Mesoporous materials and methods
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
EP1408978A4 (en) NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
IL154553A0 (en) Urocortin-iii and uses thereof
GB2376073B (en) Fluid-gauging systems and methods
IL159215A0 (en) A solution of interleukin-13 and methods utilizing the same
EP1422989A4 (en) METHOD AND FEED FOR ENHANCING RUMINANT ANIMAL PRODUCTIVITY
AU2002359694A8 (en) Compounds and methods
GB0126889D0 (en) Compounds and their uses
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
EP1408985A4 (en) NEW PYRIDOPYRIMIDONE AND ITS USES
EP1418194A4 (en) MODIFIED POLYALKYLENEIMINE AND METHODS OF USE
GB0111496D0 (en) Therapeutic systems and methods
PL363290A1 (en) 1k-polyurethane lacquer and use thereof
GB2382598B (en) Construction and elongate members therefor
EP1379240A4 (en) CONNECTIONS AND METHODS
EP1367123A4 (en) NEUROTONIN AND ITS USE